Paul Stellato

Zimmer Biomet Holdings, Inc., a global leader in medical technology, has announced a leadership transition within its finance organization. Suketu Upadhyay, Chief Financial Officer and Executive Vice President of Finance, Operations, and Supply Chain, has departed the company to pursue a new professional opportunity.

To ensure continuity during the transition, Zimmer Biomet has appointed Paul Stellato as Interim Chief Financial Officer while the company conducts both internal and external searches for a permanent successor. Stellato currently serves as Controller, Chief Accounting Officer, and Head of Corporate Financial Planning and Analysis (FP&A).

With more than 20 years of experience in finance, accounting, and investor relations, Stellato brings extensive leadership expertise to the interim role. Since joining Zimmer Biomet in May 2022, he has played a key role in advancing the company's strategic transformation through disciplined capital allocation, supporting acquisitions, and overseeing the company's share repurchase program.

Before joining Zimmer Biomet, Stellato held several senior finance leadership positions at Xylem Inc., including Vice President of Finance for Global Business Services, Vice President, Controller and Chief Accounting Officer, and Vice President of Financial Planning and Analysis. Earlier in his career, he spent eight years at ITT Corporation in progressively senior finance roles and began his professional journey in public accounting with Andersen and Ernst & Young.

Stellato holds a Bachelor of Science in Accountancy from Villanova University and a Master of Business Administration from New York University's Stern School of Business. He is also a Certified Public Accountant (CPA). His appointment is expected to provide financial leadership and operational continuity as Zimmer Biomet continues its search for a permanent Chief Financial Officer.